设为首页收藏本站
开启辅助访问
切换到窄版

 找回密码
 注册

QQ登录

只需一步,快速开始

搜索
查看: 511|回复: 0

CAR修饰的T/NK细胞在多发性骨髓瘤中的应用

[复制链接]
发表于 2016-1-7 00:05:25 | 显示全部楼层 |阅读模式
Application of Chimeric Antigen Receptor-Modified CAR-T/NK Cells to Treatment of Multiple Myeloma
Chimeric antigen receptor(CAR) is a synthesized transmembrane protein, which redirects the modified cells through specific or associated antigen on tumor cells. CAR-modified T/NK cells, especially CAR-T cells, are a new tool of rapidly developing of adoptive immunotherapy of tumor in recent years, they give T/NK cells the targeting cytotoxic activity and can overcome the tumor immunosuppressive microenvironment and break the state of the host immune tolerance. CAR combines the single-chain antibody to tumor-associated antigen with T/NK cells' activated motifs, giving T/NK cells' tumor targeting activity, so enhancing their cytotoxic activity and lasting the vitality by gene transduction. In this article the CAR development, comparison of CAR-T and CAR-NK cells, surface markers on MM cells and use of CAR in MM, and CAR perspectives are summarized.
CAR修饰的T/NK细胞在多发性骨髓瘤中的应用
嵌合抗原受体(CAR)是一种合成的跨膜蛋白,它能够通过特异的或者相关的抗原介导修饰的细胞到达肿瘤细胞。CAR修饰的T/NK细胞,尤其是CAR-T细胞,是一种近年来快速发展起来的新型对抗肿瘤的过继免疫治疗技术。这种技术能够赋予T/NK细胞靶向杀伤活性,并且能够克服肿瘤的免疫抑制微环境和打破宿主免疫耐受的状态。CAR结合单链抗体到达肿瘤相关抗原,从而赋予了T/NK细胞靶向的抗肿瘤活性。因此,增加它们的杀伤活性和维持他们的活性需要通过基因转导的方式。在这篇文章中,将会总结CAR的发展,CAR-TCAR-NK细胞技术的比较,MM细胞表面的标记物和CARMM疾病中的应用以及 CAR治疗的一些观点。
出自爱康得生物技术

您需要登录后才可以回帖 登录 | 注册

本版积分规则

QQ|申请友链|小黑屋|手机版|Archiver|生物信息学论坛 ( 蜀ICP备09031721号  

GMT+8, 2017-3-27 12:49 , Processed in 0.104740 second(s), 24 queries .

Powered by Discuz! X3

© 2001-2013 Comsenz Inc.

快速回复 返回顶部 返回列表